SCHEMBL23769075

SCHEMBL23769075

Cc1cc(CN2C(=O)CSc3ccc(NC(=O)Nc4ccc5cc[nH]c5c4)cc32)ccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 7/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
ALDH1A1 P00352 5/20 0.49
USP2 O75604 5/20 0.49
NPC1 O15118 2/20 0.49
LMNA P02545 2/20 0.49
RAB9A P51151 2/20 0.49
HBB P68871 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAPT P10636 12/20 0.47
KMT2A Q03164 7/20 0.46
MEN1 O00255 6/20 0.46
HTT P42858 4/20 0.46
OPRM1 P35372 1/20 0.46
OPRD1 P41143 1/20 0.46
TP53 P04637 2/20 0.46
TSHR P16473 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
POLB P06746 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29978714 1.00 MAPK1 (0.49) MAPK1SMN1; SMN2ALDH1A1USP2NPC1
SCHEMBL23768795 0.87 MAPT (0.49) MAPK1SMN1; SMN2ALDH1A1USP2NPC1
SCHEMBL29978870 0.87 MAPT (0.49) MAPK1SMN1; SMN2ALDH1A1USP2NPC1
SCHEMBL29979471 0.83 MAPT (0.45) MAPK1SMN1; SMN2ALDH1A1USP2NPC1
SCHEMBL25138405 0.83 MAPT (0.45) MAPK1SMN1; SMN2ALDH1A1USP2NPC1
SCHEMBL23769076 0.80 MAPT (0.49) MAPK1SMN1; SMN2ALDH1A1USP2NPC1
SCHEMBL23769077 0.79 ALDH1A1 (0.69) MAPK1SMN1; SMN2ALDH1A1USP2NPC1
SCHEMBL23768801 0.79 MAPT (0.45) SMN1; SMN2ALDH1A1LMNAMAPTKMT2A
SCHEMBL25028539 0.79 MAPT (0.49) MAPK1SMN1; SMN2ALDH1A1USP2LMNA
SCHEMBL30248606 0.79 MAPT (0.49) MAPK1SMN1; SMN2ALDH1A1USP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 CN claimed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
WO-2021161230-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS MAPK1 2469/4885SMN1; SMN2 1579/4885ALDH1A1 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.